Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 3
Journal homepage
779
Views
13
CrossRef citations to date
0
Altmetric
Letter

Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Ryu WatanabeDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Tomonori IshiiDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, JapanCorrespondence[email protected]
,
Kyoko ArakiDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Mariko IshizukaDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Yukiko KamogawaDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Yoko FujitaDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Yuko ShirotaDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Hiroshi FujiiDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
&
Hideo HarigaeDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
 show all
Pages 465-466 | Received 04 Nov 2014, Accepted 23 Jan 2015, Published online: 29 Jun 2015
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis." Modern Rheumatology, 26(3), pp. 465–466

Acknowledgment

We would like to thank Dr. Manabu Fujimoto, the Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Japan, for the measurement of anti-MDA5 antibody. The treatment protocol was approved by the Ethical Committee of Tohoku University Graduate School of Medicine.

Conflict of interest

None.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.